The 10 Best Dividend Income Growers in the S&P 500
It’s been 8 and a half years since Abbott Laboratories (NYSE: ABT) spun off its branded drug unit into a publicly-traded company. At the time, AbbVie had annual revenue of $18.4 billion. Half of its annual sales came from Humira, the company’s biologic therapy intended to treat autoimmune diseases such as psoriasis, rheumatoid arthritis, Crohn’s disease and the like. Today, ABBV has $45.8 billion in sales (2020) and $11.4 billion in operating earnings. Humira now accounts for 43% of its overall sales, down from 61% in 2018. AbbVie increased its quarterly dividend by 10.2% to $1.30 per ...
Source: investorplace.com